Erectile Dysfunction After Percutaneous Coronary Intervention Versus the Thrombolytic Therapy in Acute ST Elevation Myocardial Infarction
Condition(s):STEMILast Updated:November 7, 2017Unknown status
Hide Studies Not Open or Pending
Condition(s):STEMILast Updated:November 7, 2017Unknown status
Condition(s):Acute Coronary Syndrome; CYP2C19 PolymorphismLast Updated:July 3, 2023Recruiting
Condition(s):Psoriatic ArthritisLast Updated:March 20, 2023Completed
Condition(s):Myocardial Infarction (MI)Last Updated:April 13, 2022Completed
Condition(s):Prostate CancerLast Updated:May 9, 2013Completed
Condition(s):Heart Failure, Systolic; KetonemiaLast Updated:December 3, 2021Completed
Condition(s):Cerebrovascular AccidentLast Updated:October 31, 2013Completed
Condition(s):Hypertension; Hypertension Resistant to Conventional Therapy; Angiographically Proven Grade III Unilateral or Bilateral Atherosclerotic Renal Artery Stenosis (ARAS) Greater Than or Equal to 60 PercentLast Updated:January 26, 2018Terminated
Condition(s):Asthma; Atrial Fibrillation; Chronic Obstructive Pulmonary Disease; Coronary Artery Disease; Congestive Heart Failure; Hyperlipidemia; Hypertension; Myocardial Infarction; Sickle Cell Disease; Sleep Apnea; Smoking; Stroke; TuberculosisLast Updated:February 8, 2023Completed
Condition(s):Grey-zone Fractional Flow Reserve; Intermediate Coronary Lesions; Stable Angina; Coronary PhysiologyLast Updated:March 3, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.